• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

类风湿关节炎疾病活动的患者报告结局测量:基于 COSMIN 指南的系统评价。

Patient Reported Outcome Measures for Rheumatoid Arthritis Disease Activity: a systematic review following COSMIN guidelines.

机构信息

Centre for Trials Research, Cardiff University, Cardiff, UK

Bristol Centre for Surgical Research, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.

出版信息

RMD Open. 2022 Mar;8(1). doi: 10.1136/rmdopen-2021-002093.

DOI:10.1136/rmdopen-2021-002093
PMID:35351807
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8966547/
Abstract

BACKGROUND

The current standard of care in rheumatoid arthritis (RA) requires regular assessment of disease activity (DA). All standard RA DA measurement instruments require joint counts to be undertaken by a healthcare professional with/without a blood test. Few healthcare providers have the capacity to assess patients as frequently as stipulated by guidelines. Patient Reported Outcome Measures (PROMs) could be an efficient and informative way to assess RA DA, which is highlighted by the SARS-COV-2 pandemic, as most consultations are remote rather than face-to-face. We aimed to assess all PROMs for RA DA against the internationally recognised COSMIN guidelines to provide evidence-based recommendations to select the most suitable PROMs.

METHODS

Review registered on PROSPERO as CRD42020176176. The search strategy was based on a previous similar systematic review and expanded to include all articles up to January 2019. All identified articles were rated by two independent assessors following the COSMIN guidelines.

RESULTS

668 abstracts were identified, with 10 articles included. A further 21 were identified from a previous review. Ten PROMs were identified. There was insufficient evidence to place any of the identified PROMs into recommendation for use category A due to lack of evidence for content validity, as stipulated by the COSMIN guidelines.

CONCLUSION

Lack of evidence of content validity limits suitable PROM selection, therefore none can be recommended for use. It is acknowledged that all included PROMs were developed before the COSMIN guidelines were published. Future research on PROMs for RA DA must provide evidence of content validity.

摘要

背景

类风湿关节炎 (RA) 的当前治疗标准需要定期评估疾病活动度 (DA)。所有标准的 RA DA 测量仪器都需要由医疗保健专业人员进行关节计数,无论是否进行血液检查。很少有医疗保健提供者有能力按照指南规定的频率评估患者。患者报告的结果测量 (PROMs) 可能是评估 RA DA 的一种有效且信息丰富的方法,这在 SARS-COV-2 大流行中得到了强调,因为大多数咨询都是远程的而不是面对面的。我们旨在根据国际认可的 COSMIN 指南评估所有 RA DA 的 PROMs,为选择最合适的 PROMs 提供循证建议。

方法

在 PROSPERO 上注册的综述,编号为 CRD42020176176。搜索策略基于以前的类似系统评价,并扩展到包括截至 2019 年 1 月的所有文章。所有确定的文章均按照 COSMIN 指南由两名独立评估者进行评估。

结果

共确定了 668 篇摘要,其中有 10 篇文章被纳入。从以前的综述中又确定了 21 篇。确定了 10 种 PROMs。由于缺乏 COSMIN 指南规定的内容有效性证据,没有任何一种已确定的 PROM 可以被归入使用推荐类别 A。

结论

缺乏内容有效性的证据限制了合适 PROM 的选择,因此没有一种可以推荐使用。需要承认的是,所有纳入的 PROM 都是在 COSMIN 指南发布之前开发的。未来针对 RA DA 的 PROM 研究必须提供内容有效性的证据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f09/8966547/ed5e71cc8c8c/rmdopen-2021-002093f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f09/8966547/ed5e71cc8c8c/rmdopen-2021-002093f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f09/8966547/ed5e71cc8c8c/rmdopen-2021-002093f01.jpg

相似文献

1
Patient Reported Outcome Measures for Rheumatoid Arthritis Disease Activity: a systematic review following COSMIN guidelines.类风湿关节炎疾病活动的患者报告结局测量:基于 COSMIN 指南的系统评价。
RMD Open. 2022 Mar;8(1). doi: 10.1136/rmdopen-2021-002093.
2
The suitability of patient-reported outcome measures used to assess the impact of hypoglycaemia on quality of life in people with diabetes: a systematic review using COSMIN methods.用于评估低血糖对糖尿病患者生活质量影响的患者报告结局测量工具的适用性:使用 COSMIN 方法的系统评价。
Diabetologia. 2021 Jun;64(6):1213-1225. doi: 10.1007/s00125-021-05382-x. Epub 2021 Feb 2.
3
Patient-reported outcome measures for post-COVID-19 condition: a systematic review of instruments and measurement properties.新冠后状况的患者报告结局指标:对工具和测量特性的系统评价
BMJ Open. 2024 Dec 20;14(12):e084202. doi: 10.1136/bmjopen-2024-084202.
4
COSMIN guideline for systematic reviews of patient-reported outcome measures version 2.0.COSMIN 患者报告结局测量系统评价指南 2.0 版。
Qual Life Res. 2024 Nov;33(11):2929-2939. doi: 10.1007/s11136-024-03761-6. Epub 2024 Aug 28.
5
Evaluating patient-reported outcome measures (PROMs) for bladder cancer: a systematic review using the COnsensus-based Standards for the selection of health Measurement INstruments (COSMIN) checklist.评估膀胱癌患者报告结局测量指标(PROMs):使用共识基础的健康测量仪器选择标准(COSMIN)清单进行的系统评价。
BJU Int. 2018 Nov;122(5):760-773. doi: 10.1111/bju.14368. Epub 2018 Jun 8.
6
Measurement Properties of Patient-Reported Outcome Measures for Medication Adherence in Cardiovascular Disease: A COSMIN Systematic Review.患者报告的心血管疾病药物治疗依从性结局测量指标的测量特性:COSMIN 系统评价。
Clin Drug Investig. 2022 Nov;42(11):879-908. doi: 10.1007/s40261-022-01199-7. Epub 2022 Oct 1.
7
Methodological quality of dignity-related patient reported outcome measures used in acute hospital settings: A systematic review using the COSMIN methodology.尊严相关的患者报告结局测量在急性医院环境中的使用的方法学质量:使用 COSMIN 方法学的系统评价。
J Clin Nurs. 2023 Aug;32(15-16):4249-4264. doi: 10.1111/jocn.16598. Epub 2023 Jan 5.
8
Patient-Reported Outcome Measures for Health-Related Quality of Life in Patients With Psoriasis: A Systematic Review.患者报告的银屑病患者健康相关生活质量结局测量指标:系统评价。
JAMA Dermatol. 2024 May 1;160(5):550-563. doi: 10.1001/jamadermatol.2023.5439.
9
Use of Patient-Reported Outcome Measures to Assess Outpatient Postpartum Recovery: A Systematic Review.使用患者报告结局测量评估门诊产后康复:系统评价。
JAMA Netw Open. 2021 May 3;4(5):e2111600. doi: 10.1001/jamanetworkopen.2021.11600.
10
Patient-Reported Outcome Measures for Health-Related Quality of Life in Patients With Acne Vulgaris: A Systematic Review of Measure Development and Measurement Properties.患者报告的痤疮患者健康相关生活质量结局测量指标:测量开发和测量特性的系统评价。
JAMA Dermatol. 2022 Aug 1;158(8):900-911. doi: 10.1001/jamadermatol.2022.2260.

引用本文的文献

1
Patient Reported Outcome Measures for Rheumatoid Arthritis Disease Activity: Rasch measurement theory to identify items and domains.类风湿关节炎疾病活动度的患者报告结局测量:运用拉施测量理论确定条目和领域。
Rheumatology (Oxford). 2025 Sep 1;64(9):4902-4912. doi: 10.1093/rheumatology/keaf189.
2
Efficacy and safety of CT-P47 versus reference tocilizumab: 32-week results of a randomised, active-controlled, double-blind, phase III study in patients with rheumatoid arthritis, including 8 weeks of switching data from reference tocilizumab to CT-P47.CT-P47 对比参照药物托珠单抗的疗效和安全性:在类风湿关节炎患者中开展的一项随机、活性药物对照、双盲、III 期研究的 32 周结果,其中包括将参照药物托珠单抗转换为 CT-P47 的 8 周数据。
RMD Open. 2024 Oct 18;10(4):e004514. doi: 10.1136/rmdopen-2024-004514.
3

本文引用的文献

1
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.PRISMA 2020 声明:系统评价报告的更新指南。
BMJ. 2021 Mar 29;372:n71. doi: 10.1136/bmj.n71.
2
Systematic review and meta-analysis of measurement properties of the Hip disability and Osteoarthritis Outcome Score - Physical Function Shortform (HOOS-PS) and the Knee Injury and Osteoarthritis Outcome Score - Physical Function Shortform (KOOS-PS).系统评价和荟萃分析髋关节残疾和骨关节炎结局评分 - 物理功能简表(HOOS-PS)和膝关节损伤和骨关节炎结局评分 - 物理功能简表(KOOS-PS)的测量特性。
Osteoarthritis Cartilage. 2020 Dec;28(12):1525-1538. doi: 10.1016/j.joca.2020.08.004. Epub 2020 Aug 19.
3
Development of a novel clinimetric tool: PAtient Reported Disease Activity Index in Rheumatoid Arthritis (PARDAI-RA) by PANLAR, for the assessment of patients living with rheumatoid arthritis.新型临床计量工具的开发:PANLAR 制定的用于评估类风湿关节炎患者的患者报告疾病活动指数(PARDAI-RA)。
Clin Rheumatol. 2024 Apr;43(4):1277-1285. doi: 10.1007/s10067-024-06868-w. Epub 2024 Feb 14.
Capturing remote disease activity - results of a 12-month clinical pilot of a smartphone app in NHS rheumatology clinics in Bristol.
捕捉远程疾病活动情况——布里斯托尔国民保健服务体系(NHS)风湿病诊所智能手机应用程序12个月临床试点的结果
Rheumatology (Oxford). 2020 Aug 1;59(8):2158-2161. doi: 10.1093/rheumatology/keaa015.
4
2019 Update of the American College of Rheumatology Recommended Rheumatoid Arthritis Disease Activity Measures.2019 年美国风湿病学会推荐的类风湿关节炎疾病活动度测量标准更新。
Arthritis Care Res (Hoboken). 2019 Dec;71(12):1540-1555. doi: 10.1002/acr.24042. Epub 2019 Nov 11.
5
Computerised adaptive testing accurately predicts CLEFT-Q scores by selecting fewer, more patient-focused questions.计算机自适应测试通过选择更少、更关注患者的问题来准确预测唇腭裂问卷(CLEFT-Q)得分。
J Plast Reconstr Aesthet Surg. 2019 Nov;72(11):1819-1824. doi: 10.1016/j.bjps.2019.05.039. Epub 2019 Jun 11.
6
Providing 'the bigger picture': benefits and feasibility of integrating remote monitoring from smartphones into the electronic health record.呈现“更宏观的图景”:将智能手机远程监测整合到电子健康记录中的益处与可行性
Rheumatology (Oxford). 2020 Feb 1;59(2):367-378. doi: 10.1093/rheumatology/kez207.
7
Comparison of Disease Activity Score in 28 joints with ESR (DAS28), Clinical Disease Activity Index (CDAI), Health Assessment Questionnaire Disability Index (HAQ-DI) & Routine Assessment of Patient Index Data with 3 measures (RAPID3) for assessing disease activity in patients with rheumatoid arthritis at initial presentation.比较初诊类风湿关节炎患者的红细胞沉降率 28 关节疾病活动度评分(DAS28)、临床疾病活动指数(CDAI)、健康评估问卷残疾指数(HAQ-DI)和 3 项指标的常规评估患者指数数据(RAPID3)在评估疾病活动度方面的差异。
Indian J Med Res. 2017 Nov;146(Supplement):S57-S62. doi: 10.4103/ijmr.IJMR_701_15.
8
Call for action: how to improve use of patient-reported outcomes to guide clinical decision making in rheumatoid arthritis.行动呼吁:如何改善患者报告结局的使用以指导类风湿关节炎的临床决策。
Rheumatol Int. 2018 Jun;38(6):935-947. doi: 10.1007/s00296-018-4005-5. Epub 2018 Mar 21.
9
COSMIN methodology for evaluating the content validity of patient-reported outcome measures: a Delphi study.COSMIN 方法学用于评估患者报告结局测量的内容效度:一项德尔菲研究。
Qual Life Res. 2018 May;27(5):1159-1170. doi: 10.1007/s11136-018-1829-0. Epub 2018 Mar 17.
10
Registration of systematic reviews in PROSPERO: 30,000 records and counting.PROSPERO 系统评价注册:30000 条记录,且仍在增加。
Syst Rev. 2018 Feb 20;7(1):32. doi: 10.1186/s13643-018-0699-4.